Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

PTN


Top 10 Correlated ETFs

PTN


Top 10 Correlated Stocks

PTN


In the News

12:47 29 Nov 2022 PTN

Palatin Technologies, Inc. (PTN) Q1 2023 Earnings Call Transcript

Palatin Technologies, Inc. (NYSE:PTN ) Q1 2023 Earnings Conference Call November 14, 2022 11:00 AM ET Company Participants Carl Spana - President and Chief Executive Officer Steve Wills - Executive Vice President, Chief Financial Officer and Chief Operating Officer Conference Call Participants Michael Higgins - Ladenburg Thalmann Operator Hello, ladies and gentlemen, and welcome to Palatin's First Quarter Fiscal Year 2023 Operating Results Conference Call. As a reminder, this conference call is being recorded.

10:32 29 Nov 2022 PTN

Palatin Technologies, Inc. (PTN) Reports Q1 Loss, Tops Revenue Estimates

Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 35.82% and 8.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

05:16 29 Nov 2022 PTN

Palatin to Report First Quarter Fiscal Year 2023 Results; Teleconference and Webcast to be held on November 14, 2022

CRANBURY, N.J., Nov. 9, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter fiscal year 2023 operating results on Monday, November 14, 2022, before the open of the U.S. financial markets.

03:25 29 Nov 2022 PTN

Palatin: Inhibitor Drug With Potential In Several Autoimmune Disorders

PL9643 is being explored in a phase 3 study treating patients with Dry Eye Disease; Results from this late-stage study are expected in Q2 of 2023. The global dry eye disease market is expected to become a $7.78 billion market by 2025.

04:15 29 Nov 2022 PTN

Palatin to Report Fourth Quarter and Fiscal Year End 2022 Results; Teleconference and Webcast to be held on September 22, 2022

CRANBURY, N.J. , Sept. 19, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2022 operating results on Thursday, September 22, 2022, before the open of the U.S. financial markets.

01:27 29 Nov 2022 PTN

Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q3 2022 Results - Earnings Call Transcript

Palatin Technologies, Inc. (NYSE:PTN ) Q3 2022 Results Conference Call May 17, 2022 11:00 AM ET Company Participants Carl Spana - President and Chief Executive Officer Steve Wills - Executive Vice President, Chief Financial Officer and Chief Operating Officer Conference Call Participants Joe Pantginis - H.C Farhana Sakloth - Ladenburg John Newman - Canaccord Operator Hello, ladies and gentlemen, welcome to Palatin's Third Quarter Fiscal Year 2022 Operating Results Conference Call. As a reminder, this call is being recorded.

09:47 29 Nov 2022 PTN

Palatin Technologies, Inc. (PTN) Reports Q3 Loss, Misses Revenue Estimates

Palatin Technologies, Inc. (PTN) delivered earnings and revenue surprises of 0% and 62.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

09:02 29 Nov 2022 PTN

Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022

CRANBURY, N.J. , May 11, 2022 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2022 operating results on Tuesday, May 17, 2022, before the open of the U.S. financial markets.

01:02 29 Nov 2022 PTN

Palatin to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference

Posters highlight Palatin's ocular research and PL9643 Phase 2 clinical data CRANBURY, N.J. , May 2, 2022 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system, today announced two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Conference being held May 1-4 in Denver.

12:38 29 Nov 2022 PTN

Best Penny Stocks Today? 4 To Buy For Under $1 According To Reddit

Popular Reddit penny stocks to watch under $1. The post Best Penny Stocks Today?

Financial details

Company Rating
Buy
Market Cap
43.69M
Income
-37.34M
Revenue
2.18M
Book val./share
0.88
Cash/share
2.2
Dividend
-
Dividend %
-
Employees
33
Optionable
No
Shortable
Yes
Earnings
13 Feb 2023
P/E
-26.88
Forward P/E
-
PEG
-26.42
P/S
18.66
P/B
4.81
P/C
1.75
P/FCF
-1.25
Quick Ratio
1.46
Current Ratio
1.65
Debt / Equity
0.07
LT Debt / Equity
0.07
-
-
EPS (TTM)
-3.91
EPS next Y
-
EPS next Q
-
EPS this Y
6.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-53.44%
Revenue Q/Q
12.83%
EPS Q/Q
-35.82%
-
-
-
-
SMA20
-17.84%
SMA50
-40.23%
SMA100
-39.63%
Inst Own
0.36%
Inst Trans
-7.34%
ROA
-135%
ROE
-170%
ROC
-3.24%
Gross Margin
89%
Oper. Margin
-1750%
Profit Margin
-1714%
Payout
-
Shs Outstand
9.29M
Shs Float
8.4M
-
-
-
-
Target Price
125
52W Range
3.99-24.0
52W High
-83.92%
52W Low
+28.67%
RSI
35.36
Rel Volume
0.47
Avg Volume
91.19K
Volume
42.85K
Perf Week
-6.76%
Perf Month
-25.05%
Perf Quarter
-54.59%
Perf Half Y
-57.11%
-
-
-
-
Beta
0.832789
-
-
Volatility
0.18%, 0.47%
Prev Close
-8.53%
Price
3.86
Change
-11.26%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-06-30

Metric History 2018-06-302019-06-302020-06-302021-06-30 2022-06-30
Revenue per share
8.477.260.01-0.020.15
Net income per share
3.124.31-2.39-3.55-3.79
Operating cash flow per share
0.21-2.624.4-2.39-3.14
Free cash flow per share
0.21-2.634.4-2.39-3.16
Cash per share
4.85.248.836.353.14
Book value per share
3.412.18.545.251.7
Tangible book value per share
3.412.18.545.251.7
Share holders equity per share
3.412.18.545.251.7
Interest debt per share
0.980.090.140.130.12
Market cap
188.2M193.13M138.46M120.69M66.81M
Enterprise value
156.48M149.96M56.88M61.84M38.02M
P/E ratio
7.625.4-6.17-3.59-1.85
Price to sales ratio
2.83.21.17K-639.9445.49
POCF ratio
110.5-8.873.35-5.33-2.23
PFCF ratio
111.98-8.853.36-5.33-2.21
P/B Ratio
6.981.921.732.434.11
PTB ratio
6.981.921.732.434.11
EV to sales
2.332.49482.06-327.8925.89
Enterprise value over EBITDA
5.954.14-2.55-1.84-1.05
EV to operating cash flow
91.88-6.881.38-2.73-1.27
EV to free cash flow
93.11-6.871.38-2.73-1.26
Earnings yield
0.130.19-0.16-0.28-0.54
Free cash flow yield
0.01-0.110.3-0.19-0.45
Debt to equity
0.0100.010.020.04
Debt to assets
0.310.040.060.260.55
Net debt to EBITDA
-1.21-1.193.651.760.8
Current ratio
3.5824.9421.286.272.13
Interest coverage
17.8685.6-1.17K-1.42K-1.23K
Income quality
0.07-0.61-1.840.670.83
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.130.1682.7700
Research and developement to revenue
0.490.25118.31-68.5414.52
Intangibles to total assets
00000
Capex to operating cash flow
-0.010000.01
Capex to revenue
00-0.530.03-0.18
Capex to depreciation
-0.4-0.62-0.98-0.11-2.06
Stock based compensation to revenue
0.050.0626.6-16.81.71
Graham number
15.4534.2521.4320.4712.06
ROIC
0.920.36-0.29-0.59-1.85
Return on tangible assets
0.630.34-0.26-0.5-1
Graham Net
3.2710.188.314.671.25
Working capital
27.75M100.23M79.66M55.4M18.34M
Tangible asset value
00000
Net current asset value
26.46M100.23M78.71M48.26M14.79M
Invested capital
0.2300.020.030.07
Average receivables
030.92M01.58M1.68M
Average payables
1.43M572.72K678.16K640.65K1.9M
Average inventory
0001.16M1.05M
Days sales outstanding
0364.790-3.06K442.44
Days payables outstanding
0001.58K5.3K
Days of inventory on hand
0002.87K1.58K
Receivables turnover
010-0.120.82
Payables turnover
0000.230.07
Inventory turnover
0000.130.23
ROE
0.920.36-0.28-0.68-2.23
Capex per share
00-0.010-0.03

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q1

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
0.020.030.020.080.09
Net income per share
-0.75-0.91-0.8-1.34-0.86
Operating cash flow per share
-0.67-0.66-0.99-0.81-0.89
Free cash flow per share
-0.68-0.67-1-0.81-0.91
Cash per share
5.614.973.953.142.2
Book value per share
4.513.692.941.70.88
Tangible book value per share
4.513.692.941.70.88
Share holders equity per share
4.513.692.941.70.88
Interest debt per share
0.120.140.130.120.11
Market cap
104.82M121.52M109.85M66.81M57.04M
Enterprise value
52.56M75.57M73.4M38.02M36.88M
P/E ratio
-3.68-3.5-3.6-1.31-1.73
Price to sales ratio
657.27377.23508.3486.6865.59
POCF ratio
-16.32-19.32-11.57-8.65-6.65
PFCF ratio
-16.17-19.05-11.48-8.61-6.54
P/B Ratio
2.443.453.914.116.75
PTB ratio
2.443.453.914.116.75
EV to sales
329.59234.6339.6549.3342.41
Enterprise value over EBITDA
-7.41-8.73-9.68-2.99-4.47
EV to operating cash flow
-8.18-12.02-7.73-4.93-4.3
EV to free cash flow
-8.11-11.85-7.67-4.9-4.23
Earnings yield
-0.07-0.07-0.07-0.19-0.14
Free cash flow yield
-0.06-0.05-0.09-0.12-0.15
Debt to equity
0.020.030.030.040.07
Debt to assets
0.280.340.360.550.69
Net debt to EBITDA
7.375.314.812.272.44
Current ratio
5.973.713.532.131.65
Interest coverage
-1.28K-3.05K-2.59K-717.51-911.55
Income quality
0.90.721.240.61.04
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
21.8516.8423.059.656.93
Intangibles to total assets
00000
Capex to operating cash flow
0.010.010.0100.02
Capex to revenue
-0.36-0.28-0.36-0.05-0.16
Capex to depreciation
-4.6-3.23-1.76-0.87-2.37
Stock based compensation to revenue
3.971.942.470.930.5
Graham number
8.78.77.277.164.11
ROIC
-0.14-0.22-0.25-0.66-0.74
Return on tangible assets
-0.12-0.16-0.17-0.35-0.3
Graham Net
3.983.22.421.250.41
Working capital
48.6M37.5M30.27M18.34M10.32M
Tangible asset value
00000
Net current asset value
41.63M33.57M26.51M14.79M6.98M
Invested capital
0.030.040.050.070.12
Average receivables
1.35M1.18M1.29M1.78M1.9M
Average payables
1.96M1.66M2.78M3.16M3.47M
Average inventory
1.03M1.01M988.23K944.47K901.22K
Days sales outstanding
515.8163.16329.02207.86209.33
Days payables outstanding
1.27K494.24.61K3.25K3.93K
Days of inventory on hand
1.85K3.33K1.98K971.27892.73
Receivables turnover
0.170.550.270.430.43
Payables turnover
0.070.180.020.030.02
Inventory turnover
0.050.030.050.090.1
ROE
-0.17-0.25-0.27-0.78-0.98
Capex per share
-0.01-0.01-0.010-0.01

Frequently Asked Questions

What is Palatin Technologies, Inc. stock symbol ?

Palatin Technologies, Inc. is a US stock , located in Cranbury of New jersey and trading under the symbol PTN

What is Palatin Technologies, Inc. stock quote today ?

Palatin Technologies, Inc. stock price is $3.86 today.

Is Palatin Technologies, Inc. stock public?

Yes, Palatin Technologies, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap